aripiprazole has been researched along with Age-Related Memory Disorders in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Agai-Csongor, E; Bielik, A; Domány, G; Galambos, J; Gémesi, L; Greiner, I; Gyertyán, I; Ignácz-Szendrei, G; Keseru, GM; Kiss, B; Laszlovszky, I; Laszy, J; Magdó, I; Nógrádi, K; Sághy, K; Schmidt, E; Vágó, I; Zájer-Balázs, M | 1 |
| Białoń, M; Hereta, M; Kamińska, K; Lorenc-Koci, E; Rogóż, Z; Wąsik, A | 1 |
| Lorenc-Koci, E; Rogóż, Z; Wąsik, A | 1 |
| Cichocki, M; Jarmuszkiewicz, Z; Kus, K; Nowakowska, E; Ratajczak, P; Woźniak, A | 1 |
| Cichocki, M; Kus, K; Nowakowska, E; Ratajczak, P; Woźniak, A | 1 |
| Danielewicz, R; Herman, S; Kus, K; Nowakowska, E; Ratajczak, P; Woźniak, A | 1 |
| Adham, N; Fone, KCF; Gyertyán, I; King, MV; Kiss, B; Watson, DJG | 1 |
| Antoniów, M; Grześkowiak, E; Kus, K; Nowakowska, E; Ratajczak, P; Szkutnik-Fiedler, D | 1 |
| Furukawa, H; Kamei, H; Matsui, K; Murai, R; Nabeshima, T; Nagai, T; Noda, Y | 1 |
| Beck, A; Dembler, T; Dinges, M; Friedel, E; Gallinat, J; Heinz, A; Juckel, G; Sarkar, R; Schlagenhauf, F; Wrase, J; Wüstenberg, T | 1 |
| Fleischhacker, WW; Hoertnagl, C; Hofer, A; Pfaffenberger, N | 1 |
11 other study(ies) available for aripiprazole and Age-Related Memory Disorders
| Article | Year |
|---|---|
Novel sulfonamides having dual dopamine D2 and D3 receptor affinity show in vivo antipsychotic efficacy with beneficial cognitive and EPS profile.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Binding, Competitive; Biological Availability; Brain; Catalepsy; Cognition; Humans; Indicators and Reagents; Male; Maze Learning; Memory Disorders; Quantitative Structure-Activity Relationship; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Stereotyped Behavior; Sulfonamides | 2007 |
Effect of combined treatment with aripiprazole and antidepressants on the MK-801-induced deficits in recognition memory in novel recognition test and on the release of monoamines in the rat frontal cortex.
Topics: Animals; Antidepressive Agents; Aripiprazole; Benzazepines; Biogenic Monoamines; Citalopram; Dizocilpine Maleate; Dopamine Antagonists; Frontal Lobe; Memory Disorders; Piperazines; Pyridines; Rats; Recognition, Psychology; Serotonin Antagonists | 2020 |
Combined treatment with aripiprazole and antidepressants reversed some MK-801-induced schizophrenia-like symptoms in mice.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Disease Models, Animal; Dizocilpine Maleate; Drug Synergism; Drug Therapy, Combination; Hyperkinesis; Male; Memory Disorders; Mianserin; Mice; Mirtazapine; Recognition, Psychology; Schizophrenia; Schizophrenic Psychology | 2018 |
Influence of aripiprazole and olanzapine on behavioral dysfunctions of adolescent rats exposed to stress in perinatal period.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Benzodiazepines; Cognition Disorders; Depression; Disease Models, Animal; Drug Administration Schedule; Female; Male; Maze Learning; Memory Disorders; Olanzapine; Piperazines; Pregnancy; Prenatal Exposure Delayed Effects; Quinolones; Rats; Rats, Wistar; Schizophrenia; Stress, Psychological; Time Factors | 2013 |
The influence of aripiprazole, olanzapine and enriched environment on depressant-like behavior, spatial memory dysfunction and hippocampal level of BDNF in prenatally stressed rats.
Topics: Animals; Antidepressive Agents; Aripiprazole; Benzodiazepines; Brain-Derived Neurotrophic Factor; Depression; Environment; Female; Hippocampus; Male; Maze Learning; Memory Disorders; Olanzapine; Piperazines; Pregnancy; Quinolones; Rats; Rats, Wistar; Spatial Memory | 2014 |
Neuroleptics and enrichment environment treatment in memory disorders and other central nervous system function observed in prenatally stressed rats.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Benzodiazepines; Female; Gestational Age; Male; Maze Learning; Memory Disorders; Motor Activity; Olanzapine; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Wistar; Smoking; Social Environment | 2015 |
The dopamine D₃-preferring D₂/D₃ dopamine receptor partial agonist, cariprazine, reverses behavioural changes in a rat neurodevelopmental model for schizophrenia.
Topics: Analysis of Variance; Animals; Animals, Newborn; Antipsychotic Agents; Aripiprazole; Association Learning; Developmental Disabilities; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Exploratory Behavior; Interpersonal Relations; Locomotion; Male; Memory Disorders; Phencyclidine; Piperazines; Rats; Recognition, Psychology; Schizophrenia | 2016 |
Coadministration of tramadol with aripiprazole and venlafaxine--The effect on spatial memory functions in male rats.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Chronic Pain; Depression; Disease Models, Animal; Male; Maze Learning; Memory Disorders; Rats; Rats, Wistar; Spatial Memory; Tramadol; Venlafaxine Hydrochloride | 2016 |
Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Excitatory Amino Acid Antagonists; Exploratory Behavior; Haloperidol; Male; Memory Disorders; Mice; Mice, Inbred ICR; Motor Activity; Phencyclidine; Piperazines; Quinolones; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D1; Recognition, Psychology | 2009 |
Switching schizophrenia patients from typical neuroleptics to aripiprazole: effects on working memory dependent functional activation.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Brain Mapping; Chlorpromazine; Female; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Memory Disorders; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Oxygen; Photic Stimulation; Piperazines; Quinolones; Reaction Time; Schizophrenia; Schizophrenic Psychology; Time Factors; Visual Cortex; Young Adult | 2010 |
Aripiprazole add-on treatment in a patient with schizoaffective disorder: neurocognitive outcomes.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Drug Therapy, Combination; Humans; Male; Memory Disorders; Olanzapine; Piperazines; Psychotic Disorders; Quinolones; Treatment Outcome | 2010 |